1Aktolun C, Bayhan H, Kir M. Clinical experience with ^99mTc MIBI imaging in patients with malignant tumors: Preliminary resuhs and comparison with T1-201 [J]. Clin Nucl Med, 1992,17:171-176
2Taillefe R. Clinical applications of ^99mTc-sestamibi scintimammography[J]. Seminars in Nuclear Medicine, 2005,35:100-115
3Isabelle M,Stephane M,Bernard W,et al. Inconclusive triple diagnosis in breast cancer imaging: is there a place for scintimammography[J ]? J Nucl Med,2005,46:1574-1581
4Wilczek B, Aspelin P, Bone B, et al. Complementary use of scintimammography with ^99mTc-MIB to triple diagnostic procedure in palpable and non-palpable breast lesions [J ] . Acta Radiol,2003,44: 288-293
1Brigitte W,Leif S,Rimma D,et al.^99mTc-Exametazime as a Breast Tumor-Seeking Agent:Comparison with ^99mTc-Sestamibi.J Nucl Med,2004,45(12):2040
2Mekhmandarov S,Sandbanok J,Coben M,et al.^99mTc-MIBI scintimanmography in palpable and nonpalpable breast lesions.J Nucl Med,1998,39(1):86
3Taillefer R,Robidoux A,Jurpin S,et al.Metastatic axillary lymph node ^99mTc-MIBI imaging in primary breast cancer.J Nucl Med,1998,39(3):459
4Schulz S,Helmholz T,Schmitt J,et al.True positive somatostatin receptor scintigraphy in primary beast cancer correlates with expression of SST2A and sst5.J Breast Cancer Res Treat.,2002,72(3):221
5Chiti A,Briganti V,Fanti S,et al.Results and potential of somatostatin receptor in gastroenteropancreatic tract tumors.J Nucl Med,2000,44:42
